Overview

Safety and Efficacy of Folfox4 + Weekly Cetuximab vs Folfox 4+Biweekly Cetuximab by Metastatic Colorectal Cancer

Status:
Completed
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
To assess the efficacy of FOLFOX4 in combination with cetuximab, weekly and FOLFOX4 in combination with cetuximab, biweekly.
Phase:
Phase 2
Details
Lead Sponsor:
Central European Cooperative Oncology Group
Treatments:
Cetuximab
Oxaliplatin